P380: EX VIVO IMMUNE ACTIVATION WITH THE MACROPHAGE‐TARGETING IMMUNOTHERAPY, ANTI‐CLEVER‐1 ANTIBODY BEXMARILIMAB, IN ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME
Aakko, S., Ylitalo, A., Kuusanmäki, H., Björkman, M., Mandelin, J., Jalkanen, J., Fjällskog, M.‐L., Heckman, C., Hollmén, M., Kontro, M.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article
Personalizing precision medicine: Patients with AML perceptions about treatment decisions
Grauman, Åsa, Kontro, Mika, Haller, Karl, Nier, Samantha, Aakko, Sofia, Lang, Katharina, Zingaretti, Chiara, Meggiolaro, Elena, De Padova, Silvia, Marconi, Giovanni, Martinelli, Giovanni, Heckman, Caroline A., Simonetti, Giorgia, Bullinger, Lars, Kihlbom, Ulrik
Published in Patient education and counseling (01.10.2023)
Published in Patient education and counseling (01.10.2023)
Get full text
Journal Article
MYC-Induced miR-203b-3p and miR-203a-3p Control Bcl-xL Expression and Paclitaxel Sensitivity in Tumor Cells
Aakko, Sofia, Straume, Anne Hege, Birkeland, Einar Elvbakken, Chen, Ping, Qiao, Xi, 'Lønning, Per Eystein', Kallio, Marko J.
Published in Translational oncology (01.01.2019)
Published in Translational oncology (01.01.2019)
Get full text
Journal Article